Update on FDA Meeting Outcome Expected by End of April PRINCETON, N.J., April 3, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the… Read More..

Gross Profit Increases nearly 7-fold, Gross Margin Expands 2,150 basis points to 46.0% Hauppauge, NY, --News Direct-- Amplitech Group, Inc. McapMediaWire - AmpliTech Group, Inc. (NASDAQ: AMPG) a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and… Read More..

Company Successfully Completes Phase 2a Clinical Trial Fourth Quarter or Full Year Highlights • Appointed Douglas Johnston as CFO in November 2022 • Successfully completed Initial Public Offering, attained NASDAQ CM listing • Year-end cash balance in excess of $5 million Subsequent Events • Attended Biotech Showcase announcing successful top… Read More..